Are adherens junctions implicated in the transition from physiological to pathological cardiac hypertrophy?

被引：0
|
作者：
Prado, Cibele M. [1 ]
Blefari, Valdecir [1 ]
Santos, Daniele O. [1 ]
Malvestio, Lygia M. M. [1 ]
Pedro, Rubens F. [1 ]
Rossi, Marcos M. [1 ]
机构：
[1] Univ Sao Paulo, BR-14049 Ribeirao Preto, Brazil
来源：
FASEB JOURNAL | 2013年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
745.6
引用
收藏
页数：1
相关论文
共 50 条
  • [1] IS DYSTROPHIN ABSENCE IMPLICATED IN THE TRANSITION FROM PHYSIOLOGICAL TO PATHOLOGICAL CARDIAC HYPERTROPHY?
    Prado, C.
    Blefari, V.
    Oliveira, D.
    Silva, C. A.
    Fazan, R.
    Salgado, H. C.
    Rossi, M. A.
    [J]. HEART, 2013, 99 : A132 - A132
  • [2] Mechanisms for the transition from physiological to pathological cardiac hypertrophy
    Oldfield, Christopher J.
    Duhamel, Todd A.
    Dhalla, Naranjan S.
    [J]. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2020, 98 (02) : 74 - 84
  • [3] Physiological and pathological cardiac hypertrophy
    Shimizu, Ippei
    Minamino, Tohru
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2016, 97 : 245 - 262
  • [4] Mechanisms of physiological and pathological cardiac hypertrophy
    Nakamura, Michinari
    Sadoshima, Junichi
    [J]. NATURE REVIEWS CARDIOLOGY, 2018, 15 (07) : 387 - 407
  • [5] Mechanisms of physiological and pathological cardiac hypertrophy
    Michinari Nakamura
    Junichi Sadoshima
    [J]. Nature Reviews Cardiology, 2018, 15 : 387 - 407
  • [6] The Impact of Adherens and Tight Junctions on Physiological Function and Pathological Changes in the Retina
    Kong, Yang
    Naggert, Jurgen K.
    Nishina, Patsy M.
    [J]. RETINAL DEGENERATIVE DISEASES: MECHANISMS AND EXPERIMENTAL THERAPY, 2018, 1074 : 545 - 551
  • [7] Resveratrol prevents pathological but not physiological cardiac hypertrophy
    Vernon W. Dolinsky
    Carrie-Lynn M. Soltys
    Kyle J. Rogan
    Anita Y. M. Chan
    Jeevan Nagendran
    Shaohua Wang
    Jason R. B. Dyck
    [J]. Journal of Molecular Medicine, 2015, 93 : 413 - 425
  • [8] Resveratrol prevents pathological but not physiological cardiac hypertrophy
    Dolinsky, Vernon W.
    Soltys, Carrie-Lynn M.
    Rogan, Kyle J.
    Chan, Anita Y. M.
    Nagendran, Jeevan
    Wang, Shaohua
    Dyck, Jason R. B.
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 2015, 93 (04): : 413 - 425
  • [9] Pathological vs. physiological cardiac hypertrophy
    Kavazis, Andreas N.
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2015, 593 (17): : 3767 - 3767
  • [10] Transcriptional profiles in physiological and pathological cardiac hypertrophy
    Rodrigo, MC
    Collier, M
    Uezato, H
    Deng, D
    Bristow, J
    Simpson, PC
    [J]. CIRCULATION, 2002, 106 (19) : 34 - 34
12345